Latest News

STAT Plus: Pharmalittle: What did the lawmaker do with his biotech stock? Takeda edges closer to a Shire deal

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-predictable routine of meetings, deadlines, and the like has, of course, returned. What can you do, though? The world simply keeps spinning, even if it sometimes causes a bit of vertigo. So to cope, yes, we are firing up the coffee kettle for cups of stimulation and invite you to join us. Meanwhile, here are some tidbits to get you going. Hope today is manageable and, as always, do keep in touch. We enjoy the tips, feedback and suggestions …

New guidelines for treating high cholesterol suggest physicians consider a patient’s family history of cardiovascular disease and, in some cases, a heart scan before prescribing medicines, The Wall Street Journal writes. The guidelines also recommend prescribing two PCSK9 inhibitors for high-risk patients when statins, the traditional cholesterol-lowering medication, do not work. However, due to their cost, one PCSK9 inhibitor should be prescribed only when the other, a generic medication, doesn’t work.

Continue to STAT Plus to read the full story…

Source link

Related posts

WiFi Lets MIT Researchers Track Objects Inside Body


Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant


Food insecurity common across US higher education campuses


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World